Prognosis analysis of patients with mental disorders with COVID-19: a single-center retrospective study

Abstract

Our study aimed to investigate the factors affecting the prognosis of patients with mental disorders with COVID-19. All patients with mental disorders who were diagnosed with COVID-19 at the intensive care unit of Wuhan Mental Health Center during the period January 3 to March 1, 2020 were selected. The influence of the baseline characteristics, clinical symptoms, laboratory parameters and the types of mental disorders on prognosis were analyzed. According to their final prognosis, the patients were divided into the deceased group (5 patients) and the cured group (25 patients). The mortality rate of patients with dementia was significantly higher than that of patients with other mental disorders (P = 0.001). The levels of certain laboratory parameters in the serum of dementia patients were significantly increased compared with levels in nondementia patients (WBC count: 10.100±6.147 vs. 5.694±3.383, p = 0.029; neutrophil count: 8.504± 5.993 vs. 3.764 ± 2.733, P = 0.008; BUN: 8.300± 4.072 vs. 4.364 ± 1.196, P = 0.001). Our research indicated that the mortality rate of dementia patients with COVID-19 was higher than that of patients with other mental disorders. A focus on the inflammatory response of dementia patients may provide novel ideas for reducing mortality.

Keywords: COVID-19; dementia; inflammatory response; mental disorder.

Figure 1

Comparison of laboratory parameters between dementia and nondementia patients.

Figure 2

Correlation between inflammation and renal function. (A) Correlation analysis of BUN and neutrophil count in all patients with mental disorders; (B) correlation analysis of BUN and WBC count in all patients with mental disorders; (C) matched test of BUN and neutrophil count in dementia patients; (D) matched test of BUN and WBC count in dementia patients. ns: no significance.